ACADIA Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 8, 2017
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the second quarter ended June 30, 2017 on Tuesday, August 8, 2017, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Tuesday, August 8, 2017,